FR2862875B1 - PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ACOUPHENES - Google Patents

PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ACOUPHENES

Info

Publication number
FR2862875B1
FR2862875B1 FR0314142A FR0314142A FR2862875B1 FR 2862875 B1 FR2862875 B1 FR 2862875B1 FR 0314142 A FR0314142 A FR 0314142A FR 0314142 A FR0314142 A FR 0314142A FR 2862875 B1 FR2862875 B1 FR 2862875B1
Authority
FR
France
Prior art keywords
acouphenes
treatment
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0314142A
Other languages
French (fr)
Other versions
FR2862875A1 (en
Inventor
Stephane Mathey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MATHEY ACOUSTIQUE SERVICE
Original Assignee
MATHEY ACOUSTIQUE SERVICE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MATHEY ACOUSTIQUE SERVICE filed Critical MATHEY ACOUSTIQUE SERVICE
Priority to FR0314142A priority Critical patent/FR2862875B1/en
Publication of FR2862875A1 publication Critical patent/FR2862875A1/en
Application granted granted Critical
Publication of FR2862875B1 publication Critical patent/FR2862875B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
FR0314142A 2003-12-02 2003-12-02 PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ACOUPHENES Expired - Fee Related FR2862875B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0314142A FR2862875B1 (en) 2003-12-02 2003-12-02 PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ACOUPHENES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0314142A FR2862875B1 (en) 2003-12-02 2003-12-02 PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ACOUPHENES

Publications (2)

Publication Number Publication Date
FR2862875A1 FR2862875A1 (en) 2005-06-03
FR2862875B1 true FR2862875B1 (en) 2006-04-07

Family

ID=34566314

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0314142A Expired - Fee Related FR2862875B1 (en) 2003-12-02 2003-12-02 PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ACOUPHENES

Country Status (1)

Country Link
FR (1) FR2862875B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4299059A1 (en) 2022-07-01 2024-01-03 Labelic Analysis, S.L. Composition for the treatment of tinnitus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010004644A1 (en) * 1997-07-21 2001-06-21 Levin Bruce H. Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
ATE311867T1 (en) * 1997-09-08 2005-12-15 Warner Lambert Co ANALGESIC COMPOSITION CONTAINING ANTEPILEPTIC DRUGS AND USES THEREOF
EP1161263A1 (en) * 1999-03-10 2001-12-12 Warner-Lambert Company Llc Analgesic compositions comprising anti-epileptic compounds and methods of using same

Also Published As

Publication number Publication date
FR2862875A1 (en) 2005-06-03

Similar Documents

Publication Publication Date Title
FR13C0029I2 (en) COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
FR15C0046I2 (en) DRUGS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
DE50206657D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS
DE60239648D1 (en) Pharmaceutical compositions for the treatment of asthma
FR22C1033I1 (en) Use of dihydroimidazolones for the treatment of dogs
MA27018A1 (en) PHARMACEUTICAL DOSAGE FORM OF AMORPHOUS NELFINAVIR MESYLATE.
DE602004028763D1 (en) TE FOR THE TREATMENT OF VIRUS DISEASES
FR13C0060I2 (en) FLUORO-SUBSTITUTED OMEGA-CARBOXYARYLDIPHENYLUREA FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS
MA26992A1 (en) PHENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
NO20055010D0 (en) Preparations containing lactulose for the treatment of potavirus infections
ATE384522T1 (en) MEDICATIONS FOR THE CHEMOTHERAPEUTIC TREATMENT OF DISEASES
ATE443704T1 (en) PYRIDOPYRIMIDINONE FOR THE TREATMENT OF CANCER DISEASES
DE60204466D1 (en) INTEGRINMA TREATMENT FOR THE TREATMENT OF EYE DISEASES
MA29085B1 (en) PROPHYLACTIC OR THERAPEUTIC AGENT FOR THE TREATMENT OF SLEEP DISORDERS
ATE522218T1 (en) DOSAGE UNIT CONTAINING PROSTAGLANDIN ANALOG FOR THE TREATMENT OF INTESTINAL CONSTITUTION
DE60218375D1 (en) Pharmaceutical composition for the treatment of gynecological diseases
DE60236743D1 (en) FOR THE TREATMENT OF ANDROGEN-DEPENDENT DISEASES
DE50013843D1 (en) MEDICAMENT FOR THE TREATMENT OF DARMER DISEASES
FR2860154B1 (en) COMPOSITION FOR THE TREATMENT OF MALE BREATH
FR2800614B1 (en) COMPOSITION FOR THE TREATMENT OF RESPIRATORY INFECTIONS
DE602004010172D1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF KIDNEY FUNCTIONAL DISORDERS
FR2825279B1 (en) USEFUL MEDICINE IN THE TREATMENT OF CANCER
FR2862875B1 (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ACOUPHENES
FR2869539B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
FR2875404B1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ROSACEA

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20070831